Sushant Singh Rajput case: Late actor's family's lawyer claims NCB diverting attention; asks 'why call whole of Bollywood'? - Times of India

Vikas Singh, the attorney speaking to the group of late actor Sushant Singh Rajput has asserted that the Narcotics Control Bureau (NCB) is directing a “fashion parade” of Bollywood stars to redirect media consideration off the (*************’s) death case.

In a public interview, Singh voiced his disappointment over the new course this death test has assumed control over the previous months. Talking in insight regarding the opiates edge that surfaced during the test and is currently the argument looking into the issue, he stated, “An offence cannot be proved until some quantity of contraband is recovered. The only case made out is that of casual consumer and proving anyone guilty is almost impossible.”

He proceeded to state, “No narcotics has been seized as far as these people called by the NCB are concerned. If there is a 27(A) allegation of somebody financing this narcotics trade then that can only be against Rhea and her brother. That is the statement that has come so far about them being involved in the financing of this narcotics trade.”

#Live | I won’t state that I’m not content with the test, yet not content with the speed at which the entire case is g…

— TIMES NOW (@TimesNow) 1601041894000

“Why call the whole of Bollywood?” he asked while sharing that the late (*************’s) family feels that the consideration is presently “diverted.”

He proceeded to speculate that the NCB assuming control over the test might be with an end goal to conclude the case. He finished up saying, “If in the death of Sushant Singh Rajput, somehow, this is the purpose, then there is an effort to somehow close the case or not take it to its logical end.”

Singh’s announcements come in front of Deepika Padukone, Sara Ali Khan and Shraddha Kapoor’s planned cross examination with the focal organization on Saturday. The three Bollywood A-listers were brought after their names surfaced in certain ‘drug visits’ throughout the examination.